Get started
Author

Roman Zenouzi

Observed names: R Zenouzi, R. Zenouzi, Zenouzi, Roman
Observed institutions: Universität Hamburg, University Hospital Heidelberg, University Medical Center Hamburg-Eppendorf, Université Laval, ERN RARE-LIVER, Pomeranian Medical University
ORCID: 0000-0003-0136-0924
Observed ORCID: 0000-0003-0136-0924
OpenAlex ID: A5005287768
Transient elastography in autoimmune hepatitis: Timing determines the impact of inflammation and fibrosis
2016 · Johannes Hartl, Ulrike Denzer, et al. · Journal of Hepatology · 177
Alterations of the bile microbiome in primary sclerosing cholangitis
2019 · Timur Liwinski, Roman Zenouzi, et al. · Gut · 148
Usefulness of biochemical remission and transient elastography in monitoring disease course in autoimmune hepatitis
2017 · Johannes Hartl, Hanno Ehlken, et al. · Journal of Hepatology · 137
Altered Gut Microbial Metabolism of Essential Nutrients in Primary Sclerosing Cholangitis
2020 · Martin Kummen, Louise B. Thingholm, et al. · Gastroenterology · 127
PDF
Patient selection based on treatment duration and liver biochemistry increases success rates after treatment withdrawal in autoimmune hepatitis
2014 · Johannes Hartl, Hanno Ehlken, et al. · Journal of Hepatology · 109
Consistent alterations in faecal microbiomes of patients with primary sclerosing cholangitis independent of associated colitis
2019 · Malte Rühlemann, Timur Liwinski, et al. · Alimentary Pharmacology & Therapeutics · 100
PDF
Monocytes as Potential Mediators of Pathogen‐Induced T‐Helper 17 Differentiation in Patients With Primary Sclerosing Cholangitis (PSC)
2020 · Lilly Kristin Kunzmann, Tanja Schoknecht, et al. · Hepatology · 93
PDF
Low Risk of Hepatocellular Carcinoma in Patients With Primary Sclerosing Cholangitis With Cirrhosis
2014 · Roman Zenouzi, Tobias J. Weismüller, et al. · Clinical Gastroenterology and Hepatology · 86
PDF
Faecal microbiota profiles as diagnostic biomarkers in primary sclerosing cholangitis
2016 · Malte Christoph Rühlemann, Femke-Anouska Heinsen, et al. · Gut · 82
Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis
2017 · Moritz Peiseler, Tina Liebscher, et al. · Clinical Gastroenterology and Hepatology · 75
Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis
2016 · Hanno Ehlken, Raluca Wroblewski, et al. · PLoS ONE · 68
PDF
Features and outcome of AIH patients without elevation of IgG
2020 · Johannes Hartl, Rosa Miquel, et al. · JHEP Reports · 57
PDF
TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune Hepatitis
2019 · Claudia S Bovensiepen, Miriam Schakat, et al. · The Journal of Immunology · 53
Impact on follow‐up strategies in patients with primary sclerosing cholangitis
2022 · Annika Bergquist, Tobias J. Weismüller, et al. · Liver International · 49
PDF
Follow‐up magnetic resonance imaging/3D‐magnetic resonance cholangiopancreatography in patients with primary sclerosing cholangitis: challenging for experts to interpret
2018 · R. Zenouzi, T. Liwinski, et al. · Alimentary Pharmacology & Therapeutics · 49
PDF
Metamizole: An underrated agent causing severe idiosyncratic drug‐induced liver injury
2020 · Marcial Sebode, Martin Reike‐Kunze, et al. · British Journal of Clinical Pharmacology · 44
PDF
Gut mycobiome of primary sclerosing cholangitis patients is characterised by an increase ofTrichocladium griseumandCandidaspecies
2019 · Malte Christoph Rühlemann, Miriam Emmy Leni Solovjeva, et al. · Gut · 44
PDF
Long-term outcome in PSC/AIH “overlap syndrome”: Does immunosuppression also treat the PSC component?
2014 · Roman Zenouzi, Ansgar W. Lohse · Journal of Hepatology · 39
PDF
Risk of cholangiocarcinoma in patients with primary sclerosing cholangitis
2017 · Hanno Ehlken, Roman Zenouzi, et al. · Current Opinion in Gastroenterology · 29
Magnetic Resonance Imaging in Primary Sclerosing Cholangitis—Current State and Future Directions
2019 · Roman Zenouzi, Christopher L. Welle, et al. · Seminars in Liver Disease · 27
No Evidence That Azathioprine Increases Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis
2016 · Roman Zenouzi, Tobias J. Weismüller, et al. · Clinical Gastroenterology and Hepatology · 25
Drug‐induced liver injury at a tertiary care centre in Germany: Model for end‐stage liver disease is the best predictor of outcome
2021 · Martin Reike‐Kunze, Roman Zenouzi, et al. · Liver International · 20
PDF
Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis
2019 · Mosaab Abdulkarim, Roman Zenouzi, et al. · Scandinavian Journal of Gastroenterology · 18
Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis
2018 · S. Keller, J. Sedlacik, et al. · European Radiology · 18
Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis
2018 · Moritz Peiseler, David Reiners, et al. · PLoS ONE · 17
PDF
Works count: 78
Citation count: 1,753
H-index: 21
I10-index: 28
Year
Topic
Type